Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Why some African countries are prone to military takeovers - 2A Manual for Pick Great Lawful Discussion Administrations For New businesses In 2024
- 3NASA's Artemis 2 moon launch may be visible from Florida and southern Georgia today. Here's when to look
- 4Favored Organic product for Seniors' Prosperity: Make Your Determination
- 5A Couple of Modest Guitars for 2024
- The Best 15 Applications for Efficiency and Association
- The Longest Underwater Tunnel Connecting Germany and Denmark
- Polish law aimed at lowering petrol prices takes effect on Tuesday
- Bruno Mars tour 2026: How to get tickets for 'The Romantic Tour,' presale times, prices and more
- Understanding Successful Compromise Standards to Cultivate Agreeable Connections
- We tasted one of the 10,000 Hershey's Dubai chocolate bars being resold on eBay. Is it worth the hype?
- What's A Decent FICO rating?
- Josh Duhamel's secret to the good life at 53? Wolverine peptides, ditching Hollywood and having another baby.
- IDF: Staying in West Bank refugee camps will quell lone-wolf terror
